Meta‐analysis: analysis of mechanistic pathways in the treatment of <scp>non‐alcoholic</scp> steatohepatitis. Evidence from a Bayesian network <scp>meta‐analysis</scp>-Reference-Cited by-同舟云学术

Meta‐analysis: analysis of mechanistic pathways in the treatment of non‐alcoholic steatohepatitis. Evidence from a Bayesian network meta‐analysis

Published:2022-03-14 Issue:9 Volume:55 Page:1076-1087
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ng Cheng Han¹^ORCID,Muthiah Mark D.¹²³^ORCID,Xiao Jieling¹,Chin Yip Han¹,Lim Grace⁴,Lim Wen Hui¹,Tay Phoebe¹,Tan Darren Jun Hao¹,Yong Jie Ning¹,Pan Xin‐Hui¹,Koh Jeffery Wei Heng¹,Chew Nicholas¹,Syn Nicholas¹^ORCID,Tan Eunice¹²³,Huang Daniel Q.¹²³,Siddiqui Mohammad Shadab⁵,Loomba Rohit⁶^ORCID,Sanyal Arun J.⁵^ORCID,Noureddin Mazen⁷^ORCID

Affiliation:

1. Yong Loo Lin School of Medicine National University of Singapore Singapore

2. Division of Gastroenterology and Hepatology, Department of Medicine National University Hospital Singapore Singapore

3. National University Centre for Organ Transplantation National University Health System Singapore

4. Lee Kong Chian School of Medicine Nanyang Technological University Singapore

5. Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine Virginia Commonwealth University Richmond Virginia USA

6. NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine University of California at San Diego San Diego California USA

7. Cedars‐Sinai Fatty Liver Program, Division of Digestive and Liver Diseases, Department of Medicine, Comprehensive Transplant Center, Cedars‐Sinai Medical Centre Los Angeles California USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16808

Reference80 articles.

1. Burden of Disease due to Nonalcoholic Fatty Liver Disease

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. Drug discovery and treatment paradigms in nonalcoholic steatohepatitis

4. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

5. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery;Trends in Endocrinology & Metabolism;2024-06

2. MASH clinical trials and drugs pipeline: An impending tsunami;Hepatology;2024-03-19

3. Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action;Nefrología (English Edition);2024-03

4. Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies;Clinical Gastroenterology and Hepatology;2023-09

5. Esteatosis hepática metabólica y nefropatía diabética: una llamada a la acción;Nefrología;2023-08